Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Monday, 5 April 2021

Investor Ideas #Potcasts 548, #Cannabis News and #Stocks on the Move; (CSE: $CURA.C) (OTCQX: $CURLF), (CSE: $HOLL.C) (OTC: $HSTRF), (CSE: $MEDI.C) and BDSA

 



 

Investor Ideas #Potcasts 548, #Cannabis News and #Stocks on the Move; (CSE: $CURA.C) (OTCQX: $CURLF), (CSE: $HOLL.C) (OTC: $HSTRF), (CSE: $MEDI.C) and BDSA

 

 

Delta, Kelowna, BC, April 5, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/040521-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/04051CURA-HOLL-MEDI-BDSA.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast we look at a few public company announcements.

 

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) announced a new Curaleaf branding for the Company's recently acquired retail locations and the imminent opening of its 10th store in Illinois. Additionally, Curaleaf has contributed $950,000 to impact social equity with six strategic partnerships focused on education and job training in the greater Chicagoland community as part of its Corporate Social Responsibility Rooted in Good initiative, and per the Illinois Social Equity provision in adult use regulations.

 

Curaleaf successfully closed its acquisition of Grassroots on July 23, 2020 and has obtained final regulatory approval from the state of Illinois for the transfer of nine Greenhouse and Windy City Cannabis retail licenses. In accordance with state guidelines, Curaleaf has begun rebranding of Windy City Cannabis retail locations in Worth, Justice, and on Weed Street in Chicago in addition to Greenhouse dispensaries located in Deerfield, Mokena, Skokie, Northbrook, Melrose and Morris.

 

At the nine rebranded Illinois retail locations, Curaleaf's signature teal logo will be prominently displayed and as part of the new interior design, will feature hyper-local cityscape murals that capture each store's unique location, further enhancing the experience and connection to the community. The staff at each retail location will remain committed to delivering unparalleled service and creating an inclusive experience that encourages cannabis exploration and education with a personalized approach.

 

Later this month, Curaleaf will be hosting a Grand Opening for its brand new 4,700 square foot Westmont store, located at 11 East Ogden Avenue in Westmont, Illinois, its 10th retail location in the state and its 103rd nationwide. In addition to a ribbon cutting event to mark the occasion, all customers will receive 15% off on purchases made on their first visit to any of the new Curaleaf stores. All rebranded stores will also host a "Curaleaf Day" on April 8 with special offers, giveaways and offerings from local restaurants. 

 

"We are pleased to bring the Curaleaf brand to the greater Chicago area," said Joe Bayern, Curaleaf Chief Executive Officer. "The rebranding of these locations directly aligns with our strategy of building strong, national brands that deliver high-quality products backed by science to meet the needs of our patients and customers. We are also extremely proud to be active partners within these local communities and we look forward to building collaborative relationships and investing in long term opportunities with them."

 

This follows on the heels of Curaleef’s recent launch of Select Squeeze, a fast-acting THC-infused beverage enhancer featuring Nano-emulsification technology. The debut of Select Squeeze marked a significant milestone as one of the cannabis industry's widest national product launches. Select Squeeze was among the first cannabis products with mass availability as it became accessible to a total addressable population of 94 million adults age 21+.

 

As part of its "Rooted in Good" Corporate Social Responsibility platform, Curaleaf has contributed a total of $950,000 to six strategic partners in greater Chicagoland to create opportunities and sustainable impact within the cannabis industry.

 

Olive-Harvey College and an additional North Chicagoland community college have been selected to build programs that educate, mentor and provide internships and career opportunities within cannabis. Additionally, Curaleaf is partnering with three organizations, Cara Chicago, Growing Home and Greater West Town Community Development Project, which focus on job training to create economic opportunity and alleviate relational poverty. The Company also contributed to the Illinois Cannabis Business Development Fund, which provides technical assistance and training to support prospective entrepreneurs in applying for cannabis business establishment licenses.

 

Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) has partnered with one of California's leading distributors, Nabis, as demand for Hollister products continues to build. The new exclusive partnership will help streamline sales, grow retail opportunities and reduce wholesale delivery times on all orders.

 

Nabis supports California's cannabis market with its wholesale distribution services. Supplying more than 99% of California's dispensaries with a diverse selection of innovative products, Nabis works directly with brands to ensure timely fulfillment, and provides actionable sales data and insights to help brands scale and grow.

 

The partnership comes at a time when Hollister's portfolio of products continues to gain brand awareness. HashBone, a hash-infused pre-roll, is one of the company's signature products in California, and Hollister recently acquired one of Arizona's leading concentrate brands, Venom Extracts, which is coming soon to the California market. This month, Hollister will introduce Easyriders pre-rolls in a collectible tin as the first products from its collaboration with the iconic motorcycle lifestyle magazine. Hollister also has product collaborations with Tommy Chong and the veterans-aligned medicinal brand Tactical Relief.

"We are excited to be partnered with Nabis for our last mile fulfillment. Nabis has built a best-in-class last-mile fulfillment business that will help Hollister's brands reach more California dispensaries with reduced lead times," says Carl Saling, the Co-Founder, CEO and Director of Hollister Biosciences.

 

"While Nabis works with a wide range of cannabis brands, we always have our eye on companies with well established and diverse brand portfolios as potential partners," said Jun S. Lee, President of Nabis. "Hollister Cannabis Co. joining our family of Nabis-distributed brands is a great partnership for all parties. We look forward to distributing Hollister's high-profile, top-quality products to dispensaries across California."

 

Myconic Capital Corp. (formerly, Auralite Investments Inc.) (CSE: MEDI) announced that in its pursuit to establish an investment portfolio of leading ketamine treatment centers for depression and chronic neuropathic pain, the Company has acquired the rights to a letter of intent providing for the acquisition of all of the issued and outstanding shares of NY Ketamine Medical Practice PLLC, a leading mental health and pain clinic based in New York, New York.

 

NY Ketamine Infusions was founded in 2012 by Dr. Glen Z. Brooks who was among the first physicians in the United States using this innovative treatment to successfully care for patients suffering from treatment-resistant depression, PTSD, mood disorders and chronic neuropathic pain. Building on over 2 decades of clinical research at major institutions like Yale University and the National Institute of Mental Health (NIMH), Dr. Brooks was at the forefront of introducing this innovative treatment to patients in need. Dr. Brooks is a board-certified anesthesiologist having completed his training at Harvard’s Brigham and Women’s Hospital and has taught at Yale University School of Medicine. As of 2021, Dr. Brooks has treated over 4,000 patients with over 50,000 ketamine infusions in his New York City office alone, representing the largest single office clinical experience in the world. His internationally renowned expertise in the field of ketamine therapy and his reputation for personal patient involvement has attracted clients from North and South America, Europe, Asia and the Middle East.

 

Unlike other depression medications that can take weeks or months to take effect, relief from ketamine infusions can often be experienced by patients within hours, making it especially useful for suicidal ideation. Low doses of ketamine are generally administered through a series of six infusions over a two-week period, often followed by ongoing maintenance sessions on an “as needed” basis. In otherwise treatment resistant depression patients, numerous studies have shown that intravenous ketamine therapy has an overall success rate of 70%.

 

Based on the success of its New York City clinic, NY Ketamine Infusions has opened an additional clinic in Long Island, NY (Melville). Dr. Brooks also continues to act as a consultant for privately owned practices in Albany, NY and Madrid, Spain. He has been interviewed and quoted in numerous publications including The New York Times and was featured in Bloomberg Businessweek.1

 

Pursuant to the terms of the Letter of Intent, Myconic would acquire NY Ketamine Infusions in exchange for approximately USD $10,000,000, payable in cash and common shares, along with an additional number of common shares pursuant to achieving certain milestone events. The purchase price will be payable in three tranches collectively equal to USD $5,000,000 in cash and USD $5,000,000 in common shares over an 18-month period commencing upon the Company completing a financing of at least USD $10,000,000.

 

The shares issued at each tranche will be subject to an 18-month lock-up period, 25% of which will be released 4 months and 1 day from the respective share payment date; 37.5% of which will be released 12 months from the share payment date; and 37.5% of which will be released 18 months from the share payment date.

The common shares will be issued at a price per share equal to the volume weighted average trading price (VWAP) of the Company’s shares on the CSE for the 30-day period preceding the issuance, subject to the policies of the CSE and applicable securities laws. All securities issued pursuant to the acquisition shall be subject to a four month and one day hold period.

 

The completion of the acquisition is subject to a number of conditions which include but are not limited to the execution of the share purchase agreement and respective employment agreement(s), applicable lease agreements, any municipal, state, or federal licenses, copies of patents, trademarks, or intellectual property applications, completion of satisfactory due diligence, the delivery and satisfactory review of the financial statements of NY Ketamine Infusions, and the approval of the transaction by the boards of directors of each of Myconic and NY Ketamine Infusions.

 

BDSA, the leader in data, market intelligence and strategic guidance to the cannabis industry, announced today the availability of its new Basket Analytics solution, the most in-depth solution of its kind in the cannabis industry. BDSA Basket Analytics is now available on BDSA’s GreenEdge™ platform.

 

Retailers can maximize basket sizes and in-store experience via unique and strategic store layouts and planograms, positioning products most likely to be purchased together on shelves to encourage cross-sell and upsell opportunities. Further, retailers can unpack untapped promotional programs, educate their budtenders to increase basket size, and generate more consumer trips to the stores and higher basket sizes when in the store.

Manufacturers and brands can build strong retailer sales stories and relationships with quantitative proof of their brand’s value to a store. Further, they can drive successful innovation, better manage product portfolios, and create relevant and impactful marketing campaigns and promotions.

 

BDSA can now put specifics around how cross-brand and cross-category consumption translates to volume. Baskets containing concentrates in Colorado, for example, are among the biggest in dollar size. While concentrates tend to have a higher retail price, 20 percent of the time these shoppers are also buying flower and 14 percent of the time they are also buying edibles.

 

“Retailers are intently focused on increasing basket sizes and manufacturers must create and expand penetration within stores. Our new Basket Analytics solution with insights down to the brand level enables all cannabis industry participants to be more successful,” said Micah Tapman, CEO of BDSA. “More and better data enables manufacturers and retailers to make better informed decisions that lead to increased revenue, more effective promotions and enhanced market share. ”

 

BDSA solutions enable product development and innovation, sales and marketing activities, revenue optimization and investment decisions. Enhanced attribute coding and advanced forecasting algorithms combine to make BDSA’s market insights invaluable tools to review product attributes, velocity and distribution, and more.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash  and others.

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio ,  Google Play Music and most audio platforms available.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.

Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  


Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

Thursday, 1 April 2021

Investorideas.com - New Mexico Poised to Become the 17th State to Legalize Cannabis

Investorideas.com - New Mexico Poised to Become the 17th State to Legalize Cannabis

Investor Ideas #Potcasts 547, #Cannabis News and #Stocks on the Move; (TSX: $WEED.TO) (NASDAQ: $CGC) (NASDAQ: $CLVR)

Investor Ideas #Potcasts 547, #Cannabis News and #Stocks on the Move; (TSX: $WEED.TO) (NASDAQ: $CGC) (NASDAQ: $CLVR)

 


Delta, Kelowna, BC, April 1, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/040121-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/04011WEED-CGC-CLVR.asp

 

Hear the investor ideas potcast on Spotify

 

Hear Investor ideas cannabis potcast on iTunes  

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast we look at a few public company announcements.

 

 

Ikänik Farms Inc. (Formerly Canadian Imperial Venture Corp.) announced that, further to its news release dated March 30, 2021, the Company has received final approval from the Canadian Securities Exchange and will commence trading on the CSE under the symbol "IKNK", beginning April 6, 2021.

 

"I would like to thank our investors for their patience, and everyone involved who helped us get to where we are today. We are excited for what lies ahead in our pursuit to deliver value to our shareholders," said Brian Baca, CEO of Ikänik.

 

"We are pleased to begin trading on the CSE and proud of the major milestone it represents for our company" said Borja Sanz de Madrid, President Ikänik International Inc.

 

The Company has remained focused on international operations and Latin America positioning, completing all certifications required to export pharmaceutical grade cannabis flower and full-spectrum cannabis oil to international clients. Ikänik has entered the global, pharmaceutical cannabis market through its Colombian operations, Pideka SAS ("Pideka") and will support the European Union and Latin American markets with flower and finished ingredient cannabis oil, produced in its Casa Flores facility. Pideka was the first company in Colombia to export THC for commercial sale and the first to export THC to Mexico, contributing to the legalization of the process in both respective countries, when the process was complete. Pideka is also the first indoor, vertical cultivator of pharmaceutical grade cannabis producer in Colombia. The Company's certifications and operating efficiencies enable production of cost-effective, indoor cannabis and provides access to international markets.

 

Ikänik is in the process of entering the Mexican cannabis market, through the acquisition of Delta 9 Corporation in 2020. Through D9C, Ikänik holds the sole legalized "Amparo" in Mexico permitting the importation and registration of cannabis and hemp seeds, legalizing the commercial process to cultivate, manufacture, distribute both finished and bulk products nationally. The principals of D9C are seasoned regulatory and political experts who have been working hand-in-hand with legislators and heads of government to advance the legal framework for cannabis legalization in the country.

 

Ikänik's California operations have been led by its state-of-the-art technology-based distribution platform to execute and deliver value and efficiency to its customers. The Company's derives strength from the wholesale of house brands and third-party service offerings, such as co-packing, order fulfillment, and sales services to brands and cultivators.

Ikänik's 9,600 square foot indoor, vertical cultivation facility in Sacramento, CA is anticipated to be fully operational by May 2021, with a first harvest delivery of Ikänik's award-winning flower in Q2, to support both company operated and third-party dispensaries.

 

The Company is set to open its first dispensary and consumption lounge in Palm Springs with a target opening in June 2021. The dispensary features 2,200 square feet of retail space and an 1,800 square feet lounge, which we designed to accommodate the post-COVID consumer, through online order reservations, curbside pickup, and doorstep delivery options.

 

Additionally, Ikänik has expanded its category offering to include hemp-based CBD topical lotions and sports rubs under both Ikänik and Pideka brand names to independent sports retail stores and country distributors and sold over fifty-thousand units in the first quarter of this year. To support the Ikänik brand the Company has partnered and enrolled global athletes into its ambassador program with the recent signing of legendary surf icon, Rob Machado, a 30-year professional surfer and one of the sport's largest names.

 

The Company has teamed with up-and-coming snowboarding phenom, Toby Miller, to support and promote the Ikänik CBD brand among the athletic community. Toby has placed in the X games before and has made the invitation list to compete on this year's "invitation-only" platform. Along with earning a position on the US Snowboard team, for the men's halfpipe competition in the up coming winter Olympics.

 

Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) announced that it has completed the acquisition of AV Cannabis Inc. ("Ace Valley") - one of Ontario's leading cannabis brands. With a strong focus on ready-to-enjoy ("RTE") products and a loyal following of millennial and Gen-Z consumers, the acquisition will strengthen Canopy's industry leading house of brands.

 

Through this acquisition, Canopy Growth will acquire 100 percent of Ace Valley with the intention of leveraging the Company's best-in-class national sales, marketing and distribution capabilities to expand the product portfolio and scale the brand across Canada.

"The team at Ace Valley has built a premium cannabis brand, with an impressive consumer following and we're excited to deploy the full distribution power of Canopy Growth to expand the brand to consumers across Canada," said Rade Kovacevic, President & Chief Product Officer of Canopy Growth. "Ace Valley's complementary consumer positioning fits perfectly into Canopy Growth's strategy of building authentic brands that truly resonate with consumers."

 

"This is a Canadian success story and proof of the enduring value of authentic, thoughtfully crafted brands and we're proud to have built a strong and loyal consumer following behind Ace Valley," said Mike Wagman and Jesse Dallal, Founders of Ace Valley. "Having collaborated with Canopy Growth through the early success of the brand, we're confident that the integrity of Ace Valley will endure as the talented team at Canopy Growth takes it to the next level."

 

Ace Valley holds top 5 and top 10 market positions in Ontario across its range of SKUs1 and complements Canopy Growth's existing portfolio of premium vapes, pre-roll joints, and gummies. Ace Valley has carved out a leading position and a particularly strong following among millennial and Gen-Z consumers. This success to date is a perfect example of the continued value of consumer-focused brands, confirming that many cannabis consumers are looking for premium, RTE products from brands they connect with.

 

Clever Leaves Holdings Inc. (NASDAQ: CLVR), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, today announced an agreement with Verdemed Holdings Inc. (“Verdemed”), a Latin American pharmaceutical cannabis company based in Toronto, Canada, to supply finished CBD products for the Brazilian and Peruvian markets. The initial portfolio of products includes finished formulations of CBD oral solutions with different concentrations used for different indications.

 

Verdemed supplies cannabis products in Brazil under the compassionate use model and has submitted applications to register finished products in Brazil and Peru. The products manufactured under this partnership will be registered as pharmaceutical products and sold into distribution channels such as pharmacies and drugstores.

 

“Verdemed is an important player in the Brazilian market with existing access to patients and is well-positioned to tackle the high regulatory hurdles in Brazil and Peru. This partnership expands Clever Leaves’ presence in one of the largest markets in South America,” said Kyle Detwiler, CEO of Clever Leaves. “We are committed to increasing access for the millions of patients within the growing Brazilian and Peruvian markets, and they will soon have access to the high-quality products we produce thanks to Verdemed’s network.”

 

“Partnering with Clever Leaves aligns with Verdemed’s mission to offer the best cannabinoid products to all Latin Americans,” said José Bacellar, CEO of Verdemed. “Clever Leaves’ products meet all of the regulatory and product quality standards in each of our key markets, and their EU GMP and INVIMA GMP certifications distinguish their products and bring higher value to patients.”

 

The Brazilian and Peruvian markets are expanding, and it is estimated that the Brazilian medical cannabis user base could reach close to 3 million people in the next few years. According to Prohibition Partners, with a population of 32 million, Peru’s medical cannabis market is estimated to be worth approximately $100 million. As of September 2020, almost 8,000 patients were registered in the DIGEMID, Peru’s drug regulatory authority database.

 

Finally, in legalization news, the states of New York, Virginia and New Mexico have put through new cannabis legislation.

 

New York legalized the use of recreational marijuana, enacting a robust program that will reinvest millions of dollars of tax revenues from cannabis in minority communities ravaged by the decades-long war on drugs.

 

Gov. Andrew M. Cuomo signed the cannabis legislation on Wednesday, a day after the State Legislature passed the bill following hours of debate among lawmakers in Albany.

New York became the 15th state to legalize the recreational use of cannabis, positioning itself to quickly become one of the largest markets of legal cannabis in the nation and one of the few states where legalization is directly tied to economic and racial equity.

New Mexico lawmakers also approved a bill to legalize marijuana for adults during a special legislative session on Wednesday, sending the years-in-the-making legislation to the desk of Gov. Michelle Lujan Grisham (D), who is expected to sign it into law. Lawmakers also passed separate legislation to expunge past convictions for low-level cannabis crimes.

Legal retail sales of cannabis are scheduled to begin by April 1, 2022.

“This is a significant victory for New Mexico,” Lujan Grisham said after the vote. “Workers will benefit from the opportunity to build careers in this new economy. Entrepreneurs will benefit from the opportunity to create lucrative new enterprises. The state and local governments will benefit from the additional revenue. Consumers will benefit from the standardization and regulation that comes with a bona fide industry.”

“And those who have been harmed by this country’s failed war on drugs, disproportionately communities of color, will benefit from our state’s smart, fair and equitable new approach to past low-level convictions,” she said.

In Virginia the governor on Thursday officially proposed pushing up the timeline to implement marijuana legalization—one of a series of amendments to the reform legislation that he’s submitting to lawmakers, who will consider them next week.

Gov. Ralph Northam (D) also addressed concerns over provisions dealing with home cultivation, expungements and worker protections.

Top legislators and reform advocates have been pushing for many of these changes, particularly moving up the effective date. The governor’s proposal would make it so possession of cannabis by adults 21 and older would be legal on July 1, rather than in 2024 as the measure currently stipulates.

Home cultivation would be allowed starting on July 1 as well.  Plants would have to be labeled with “identification information, out of sight of public view, and out of range of individuals under the age of 21,” a summary states.

“Our Commonwealth is committed to legalizing marijuana in an equitable way,” Northam said in a press release. “Virginia will become the 15th state to legalize marijuana—and these changes will ensure we do it with a focus on public safety, public health, and social justice. I am grateful to the advocates and legislators for their dedicated work on this important issue, and I look forward to this legislation passing next month.”

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio ,  Google Play Music and most audio platforms available.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  


Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

Trial Could Position Eco-Friendly Fertilizer for Organic Cannabis Market

Trial Could Position Eco-Friendly Fertilizer for Organic Cannabis Market